Search tips
Search criteria 


Logo of annrheumdAnnals of the Rheumatic DiseasesVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Ann Rheum Dis. 1995 April; 54(4): 289–297.
PMCID: PMC1005576

Cathepsin B in osteoarthritis: cytochemical and histochemical analysis of human femoral head cartilage.


OBJECTIVE--To localise the cysteine endopeptidase cathepsin B in chondrocytes and cartilage from normal and osteoarthritic (OA) human femoral heads in order to provide qualitative information on its cellular expression and distribution at possible sites of action. METHODS--OA articular cartilage was obtained at surgery for total hip replacement; control cartilage was obtained at postmortem. Chondrocytes were isolated by sequential enzymatic digestion and cathepsin B analysed by immunocytochemistry and activity staining with a fluorogenic substrate. Lysosomes were visualised by fluorescence microscopy after staining of living cells with acridine orange. Using a histochemical reaction, enzyme activity was measured in cryosections of full thickness cartilage. RESULTS--Chondrocytes from normal cartilage contained very few lysosomes and only a minor cell population was cathepsin B positive. A high proportion of chondrocytes from active OA cartilage contained a large number of lysosomes and an excess of cathepsin B in intracellular organelles; the enzyme was stored in an active form. In this respect, OA chondrocytes closely resembled normal cells that had been phenotypically modulated by serial subcultures. No cathepsin B activity could be detected by histochemistry in either chondrocytes or matrix of normal cartilage. While apparently intact and severely degraded OA cartilage was also cathepsin B negative, tissue at sites of active destruction and, particularly, at repair sites was highly positive. CONCLUSION--The presence and the particular distribution of active cathepsin B in OA cartilage at 'more involved' sites suggest a pathological role for this enzyme in sustaining and perpetuating cartilage degradation. While other stimuli may also be responsible for cathepsin B expression in OA chondrocytes, the similarity with artificially modulated cells indicates fibroblastic metaplasia as a plausible mechanism.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (4.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Ali SY. The degradation of cartilage matrix by an intracellular protease. Biochem J. 1964 Dec;93(3):611–618. [PubMed]
  • Ali SY, Evans L, Stainthorpe E, Lack CH. Characterization of cathepsins in cartilage. Biochem J. 1967 Nov;105(2):549–557. [PubMed]
  • Bayliss MT, Ali SY. Studies on cathepsin B in human articular cartilage. Biochem J. 1978 Apr 1;171(1):149–154. [PubMed]
  • Martel-Pelletier J, Cloutier JM, Pelletier JP. Cathepsin B and cysteine protease inhibitors in human osteoarthritis. J Orthop Res. 1990 May;8(3):336–344. [PubMed]
  • Baici A, Hörler D, Lang A, Merlin C, Kissling R. Cathepsin B in osteoarthritis: zonal variation of enzyme activity in human femoral head cartilage. Ann Rheum Dis. 1995 Apr;54(4):281–288. [PMC free article] [PubMed]
  • Buttle DJ, Saklatvala J, Tamai M, Barrett AJ. Inhibition of interleukin 1-stimulated cartilage proteoglycan degradation by a lipophilic inactivator of cysteine endopeptidases. Biochem J. 1992 Jan 1;281(Pt 1):175–177. [PubMed]
  • Buttle DJ, Saklatvala J. Lysosomal cysteine endopeptidases mediate interleukin 1-stimulated cartilage proteoglycan degradation. Biochem J. 1992 Oct 15;287(Pt 2):657–661. [PubMed]
  • Buttle DJ, Handley CJ, Ilic MZ, Saklatvala J, Murata M, Barrett AJ. Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases. Evidence for two converging pathways of chondrocyte-mediated proteoglycan degradation. Arthritis Rheum. 1993 Dec;36(12):1709–1717. [PubMed]
  • Baici A, Lang A. Effect of interleukin-1 beta on the production of cathepsin B by rabbit articular chondrocytes. FEBS Lett. 1990 Dec 17;277(1-2):93–96. [PubMed]
  • Baici A, Lang A, Hörler D, Knöpfel M. Cathepsin B as a marker of the dedifferentiated chondrocyte phenotype. Ann Rheum Dis. 1988 Aug;47(8):684–691. [PMC free article] [PubMed]
  • Baici A, Lang A. Cathepsin B secretion by rabbit articular chondrocytes: modulation by cycloheximide and glycosaminoglycans. Cell Tissue Res. 1990 Mar;259(3):567–573. [PubMed]
  • Archer CW, McDowell J, Bayliss MT, Stephens MD, Bentley G. Phenotypic modulation in sub-populations of human articular chondrocytes in vitro. J Cell Sci. 1990 Oct;97(Pt 2):361–371. [PubMed]
  • Graf FM, Sträuli P. Use of the avidin-biotin-peroxidase complex (ABC) method for the localization of rabbit cathepsin B in cells and tissues. J Histochem Cytochem. 1983 Jun;31(6):803–810. [PubMed]
  • Graf M, Baici A, Sträuli P. Histochemical localization of cathepsin B at the invasion front of the rabbit V2 carcinoma. Lab Invest. 1981 Dec;45(6):587–596. [PubMed]
  • Baici A, Gyger-Marazzi M. The slow, tight-binding inhibition of cathepsin B by leupeptin. A hysteretic effect. Eur J Biochem. 1982 Dec;129(1):33–41. [PubMed]
  • Graf M, Leeman U, Ruch F, Sträuli P. The fluorescence and bright field microscopic demonstration of cathepsin B in human fibroblasts. Histochemistry. 1979;64(3):319–322. [PubMed]
  • Dolbeare F, Vanderlaan M. A fluorescent assay of proteinases in cultured mammalian cells. J Histochem Cytochem. 1979 Nov;27(11):1493–1495. [PubMed]
  • Van Noorden CJ, Vogels IM. Enzyme histochemical reactions in unfixed and undecalcified cryostat sections of mouse knee joints with special reference to arthritic lesions. Histochemistry. 1986;86(2):127–133. [PubMed]
  • Van Noorden CJ, Vogels IM, Smith RE. Localization and cytophotometric analysis of cathepsin B activity in unfixed and undecalcified cryostat sections of whole rat knee joints. J Histochem Cytochem. 1989 May;37(5):617–624. [PubMed]
  • Mankin HJ, Dorfman H, Lippiello L, Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am. 1971 Apr;53(3):523–537. [PubMed]
  • Weiss C, Mirow S. An ultrastructural study of osteoarthritis changes in the articular cartilage of human knees. J Bone Joint Surg Am. 1972 Jul;54(5):954–972. [PubMed]
  • Weiss C. Ultrastructural characteristics of osteoarthritis. Fed Proc. 1973 Apr;32(4):1459–1466. [PubMed]
  • Barratt ME. The role of soft connective tissue in the response of pig articular cartilage in organ culture to excess of retinol. J Cell Sci. 1973 Jul;13(1):205–219. [PubMed]
  • Barratt ME. Role of the chondrocytes in the breakdown of pig articular cartilage induced by complement-sufficient antiserum to pig erythrocytes. Int Arch Allergy Appl Immunol. 1975;48(4):547–563. [PubMed]
  • Fell HB, Barratt ME, Welland H, Green R. The capacity of pig articular cartilage in organ culture to regenerate after breakdown induced by complement-sufficient antiserum to pig erythrocytes. Calcif Tissue Res. 1976 Apr 13;20(1):3–21. [PubMed]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group